The Johannes Gutenberg University Mainz is a public research university in Mainz, Rhineland Palatinate, Germany, named after the printer Johannes Gutenberg since 1946. With approximately 32,000 students in about 100 schools and clinics, it is among the largest universities in Germany.

During the past decade, Johannes Gutenberg University conducted 47 clinical trials. In the 10-year time frame, 47 clinical trials started and 17 clinical trials were completed, i.e. on average, 36.2% percent of trials that started reached the finish line to date. In the past 5 years, 19 clinical trials started and 12 clinical trials were completed. i.e. 63.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Johannes Gutenberg University" #1 sponsor was "Johannes Gutenberg University Mainz" with 10 trials, followed by "Gilead Sciences" with 6 trials sponsored, "European Organisation for Research and Treatment of Cancer - EORTC" with 5 trials sponsored, "Amgen" with 4 trials sponsored and "Boehringer Ingelheim" with 4 trials sponsored. Other sponsors include 84 different institutions and companies that sponsored additional 68 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Johannes Gutenberg University" #1 collaborator was "Johannes Gutenberg University Mainz" with 4 trials as a collaborator, "Genentech, Inc." with 3 trials as a collaborator, "Novartis" with 3 trials as a collaborator, "Australasian Gastro-Intestinal Trials Group" with 2 trials as a collaborator and "Cancer Research UK" with 2 trials as a collaborator. Other collaborators include 79 different institutions and companies that were collaborators in the rest 84 trials.

According to Clinical.Site data, the most researched conditions in "Johannes Gutenberg University" are "Colorectal Cancer" (4 trials), "Cystic Fibrosis" (4 trials), "Hepatitis C, Chronic" (4 trials), "Lymphoma" (4 trials) and "Neuroblastoma" (4 trials). Many other conditions were trialed in "Johannes Gutenberg University" in a lesser frequency.

Most popular intervention types in "Johannes Gutenberg University" are "Drug" (67 trials), "Device" (23 trials), "Biological" (18 trials), "Other" (15 trials) and "Radiation" (14 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "radiation therapy" (9 trials), "cyclophosphamide" (7 trials), "doxorubicin hydrochloride" (7 trials) and "vincristine sulfate" (7 trials). Other intervention names were less common.

The vast majority of trials in "Johannes Gutenberg University" are 115 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Johannes Gutenberg University". undefined are not yet recruiting, 13 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 75 completed trials in Johannes Gutenberg University, undefined suspended trials, and 11 terminated clinical trials to date.

Out of the total trials that were conducted in Johannes Gutenberg University, 7 "Phase 1" clinical trials were conducted, 34 "Phase 2" clinical trials and 42 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 20 trials that are defined as “Not Applicable".

Johannes Gutenberg University has several departments that took part in Clinical trials: "Department of Anesthesiology,Prof. C. Werner, Universitätsmedizin of the JG University" - 16 trials